Patents by Inventor Paola Sinibaldi Vallebona

Paola Sinibaldi Vallebona has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10214591
    Abstract: The present disclosure relates to a monoclonal antibody specifically binding to human Long Interspersed Element-1 ORF2 encoded protein (L1-ORF2p) obtained from hybridoma chA1, and derivatives and uses thereof, including for prediction of response of cancer patients to NNRTI treatments. It also relates to a method for early detection of cell transformation in pre-neoplastic tissues of a human subject, comprising detecting in cells of a pre-neoplastic tissue sample from said subject the expression of L1-ORF2p, wherein the expression of L1-ORF2p indicates the presence of cell transformation in said pre-neoplastic tissues. It also relates to a method for detecting progression of colon adenoma in a human subject suffering from colon adenoma, based on detection of an increase of L1-ORF2p expression.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: February 26, 2019
    Inventors: Corrado Spadafora, Ilaria Sciamanna, Chiara De Luca, Paola Sinibaldi-Vallebona, Fiorella Guadagni, Gerald Schumann, Enrico Garaci
  • Publication number: 20090270594
    Abstract: The invention concerns the use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies
    Type: Application
    Filed: September 27, 2007
    Publication date: October 29, 2009
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE
    Inventors: Luigina Romani, Francesco Bistoni, Enrico Garaci, Guido Rasi, Paola Sinibaldi Vallebona